Indication:
Tinea vesicolor
Tineas corpis
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Butenafine inj Antifungal 14-02-2001
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
Butanafine HCL 10mg + 15-03-2002
Betamethasone Dipropionate eq.to
Betamethasone 0.5mg cream
Superficial fungal infections dermatophytis infections
Contra-Indications:
Avoid eyes, nose, mouth, mucous mebranes,
Discontinue if irritation develops and confirm diagnosis
Do not occlude
Patient Information:
1. Use butenafine cream as directed by the physician
2. Hands should be washed after applying the medication to affected parts.
3. Avoid contact with the eyes, nose, mouth, and other mucous membranes
4. Dry the affected area throughly before appilication if you wish to apply the cream after bathing.
5. Use the medication for the full treatment recommended by the physician even though the symptoms may have improved
6. Inform the physician if the area of application shows sign of increased irritation , itching, burning, blistering, swelling, or oozing
7. Do not use this medication for any other disoders other than for which it was precscibed
Manufacturer Details